Logo Image
|Poll|May 30, 2018

Mini Quiz: Prescribing Opioids to the Elderly

The short vignettes in this quiz highlight the importance of understanding the delicate balance between risks and benefits when prescribing opioids.

In which of the following cases would you feel comfortable prescribing opioids?

A. A 78-year-old in hospice care for terminal lung cancer
B. A 68-year-old w history of depression, anxiety, chronic pain, +drug screen for cocaine/opioids/prescribed benzodiazapines
C. A 65-year-old with hepatocellular carcinoma, recently enrolled in palliative care, w a comorbid, severe alcohol-use disorder
D. A 90-year-old who has chronic back pain, neurocognitive disorder and history of falls
E. A 64-year-old status/post hip replacement surgery in PACU

Related Content

Latest CME

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care
Video

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

John Koo, MD; T.J. Chao, MPAS, PA-C

View more
Expert Illustrations & Commentary: Visualizing the Role of Novel Muscarinic Agents in the Management of Schizophrenia
Video

Expert Illustrations & Commentary: Visualizing the Role of Novel Muscarinic Agents in the Management of Schizophrenia

Ilan Melnick, MD; Linda Collado, MD, DABPN, FAPA; Maria Collado, MD, FAPA

View more
Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia
Video

Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Patricia Junquera, MD; Maria Collado, MD; Erin C. Crown, MHSPAS, PA-C, Psych-CAQ

View more
Expert Illustrations & Commentary: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder
Video

Expert Illustrations & Commentary: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Juan D. Oms, MD, FAPA; Linda Collado, MD, DABPN, FAPA; Ginger Shupe, MD

View more
(CPE Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia
Video

(CPE Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Gus Alva, MD, DFAPA; Ilan Melnick, MD

View more